Imagery rescripting and cognitive restructuring for inpatients with moderate 
and severe depression - a controlled pilot study

Kanczok, Jabin; Jauch-Chara, Kamila; Müller, Franz-Josef

doi:10.1186/s12888-024-05637-y

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Imagery rescripting and cognitive restructuring for inpatients with moderate and severe depression - a controlled pilot study

MPS-Authors

/persons/resource/persons220217

Müller, Franz-Josef
Cellular Phenotyping (Franz-Josef Müller), Dept. of Genome Regulation, (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;
Department of Psychiatry and Psychotherapy, University Hospital Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

s12888-024-05637-y.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Kanczok, J., Jauch-Chara, K., & Müller, F.-J. (2024). Imagery rescripting and cognitive restructuring for inpatients with moderate and severe depression - a controlled pilot study. BMC Psychiatry, 24(1): 194. doi:10.1186/s12888-024-05637-y.

Cite as: https://hdl.handle.net/21.11116/0000-000F-2310-7

Abstract

Background: This controlled pilot study investigates the effect of the combined use of cognitive restructuring (CR) and imagery rescripting (IR) compared to treatment as usual among inpatients with moderate and severe depression. Alongside expert ratings and self-report tools, fitness wristbands were used as an assessment tool.

Methods: In addition to the standard inpatient care (SIC) program, 33 inpatients with moderate and severe depression were randomly assigned to an intervention group (two sessions of IR and CR) or an active treatment-as-usual (TAU) control group (two sessions of problem-solving and build-up of positive activity). Depression severity was assessed by the Hamilton Depression Rating Scale-21 (HDRS-21), the Beck Depression Inventory-II (BDI-II), and as a diagnostic adjunct daily step count via the Fitbit Charge 3™. We applied for analyses of HDRS-21 and BDI-II, 2 × 2 repeated-measures analysis of variance (ANOVA), and an asymptotic Wilcoxon test for step count.

Results: The main effect of time on both treatments was η2 = .402. Based on the data from the HDRS-21, patients in the intervention group achieved significantly greater improvements over time than the TAU group (η2 = .34). The BDI-II data did not demonstrate a significant interaction effect by group (η2 = .067). The daily hourly step count for participants of the intervention group was significantly higher (r = .67) than the step count for the control group.

Conclusions: The findings support the utilization of imagery-based interventions for treating depression. They also provide insights into using fitness trackers as psychopathological assessment tools for depressed patients.